Trial intelligence / Profile preview

Naltrexone efficacy in alcoholism by OPRM1 genotype

NCT00920829Phase 4Completed

Sponsor
Medical University of South Carolina
Start
Jun 2009
Primary completion
Dec 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of naltrexone in alcohol dependence, sponsored by Medical University of South Carolina. Started Jun 2009; status: completed.

02

Drugs

naltrexone
03

Conditions

alcohol dependence

Beyond the preview

Go deeper on NCT00920829.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00920829.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call